News and Updates
eMediNexus Coverage from: 
Takeda's dengue vaccine effective overall in study but with major limitation
eMediNexus,  07 November 2019
remove_red_eye 497 Views
#Infectious Diseases #Pathology and Lab Medicine #Pediatrics #Pharmacist #Public Health

2 Read Comments                

Takeda Pharmaceutical Co’s experimental dengue vaccine was highly effective at preventing the mosquito-borne disease in a late stage study, but it failed to protect against one type of the virus in people with no prior exposure to dengue.

Takeda’s vaccine was 80.2% effective at preventing dengue among children and teens in the year after they got the shot, according to results of a Phase III study published in the New England Journal of Medicine. A preliminary analysis of Takeda’s vaccine suggests it may offer unbalanced protection among the four types of dengue… (Reuters, November 7, 2019)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now